10q10k10q10k.net
EKSO BIONICS HOLDINGS, INC.

EKSO BIONICS HOLDINGS, INC.EKSOEarnings & Financial Report

Nasdaq

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.

NextMar 19, 2026

EKSO Q3 2025 Key Financial Metrics

Revenue

$4.2M

Gross Profit

$2.5M

Operating Profit

$-1.4M

Net Profit

$-1.4M

Gross Margin

60.3%

Operating Margin

-33.2%

Net Margin

-33.6%

YoY Growth

2.4%

EPS

$-0.54

Financial Flow

EKSO BIONICS HOLDINGS, INC. Q3 2025 Financial Summary

EKSO BIONICS HOLDINGS, INC. reported revenue of $4.2M for Q3 2025, with a net profit of $-1.4M (-33.6% margin). Cost of goods sold was $1.7M, operating expenses totaled $4.0M.

Key Financial Metrics

Total Revenue$4.2M
Net Profit$-1.4M
Gross Margin60.3%
Operating Margin-33.2%
Report PeriodQ3 2025

EKSO BIONICS HOLDINGS, INC. Annual Revenue by Year

EKSO BIONICS HOLDINGS, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $17.9M).

YearAnnual Revenue
2024$17.9M
2023$18.3M
2022$12.9M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$4.8M$3.8M$5.0M$4.1M$5.1M$3.4M$2.1M$4.2M
YoY Growth36.5%-8.9%5.3%-10.4%5.0%-10.1%-58.4%2.4%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$28.9M$29.0M$27.0M$29.2M$26.7M$27.3M$23.2M$21.7M
Liabilities$16.3M$14.9M$14.9M$14.3M$13.9M$14.6M$12.2M$12.0M
Equity$12.6M$14.1M$12.1M$14.9M$12.7M$12.7M$10.9M$9.7M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-1.6M$-3.5M$-2.7M$-2.3M$-1.4M$-2.0M$-3.4M$-2.1M